Your browser doesn't support javascript.
loading
A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies.
Tsang, Erica S; Aggarwal, Rahul R; Dhawan, Mallika S; Bergsland, Emily K; Alvarez, Edwin A; Calabrese, Susan; Pacaud, Romain; Garcia, Jose; Fattah, Delaire; Thomas, Scott; Grabowsky, Jennifer; Moasser, Mark M; Munster, Pamela N.
Afiliação
  • Tsang ES; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
  • Aggarwal RR; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
  • Dhawan MS; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
  • Bergsland EK; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
  • Alvarez EA; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
  • Calabrese S; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
  • Pacaud R; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
  • Garcia J; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
  • Fattah D; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
  • Thomas S; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
  • Grabowsky J; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
  • Moasser MM; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
  • Munster PN; Division of Hematology and Oncology, University of California San Francisco, San Francisco, California.
Cancer Res Commun ; 2(7): 570-576, 2022 07.
Article em En | MEDLINE | ID: mdl-36923283

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cisplatino / Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cisplatino / Neoplasias Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article